Antibody Bank
(Kato's Lab; Tohoku University)

Kato' lab in Tohoku University Graduate School of Medicine



＜Peptide tag system＞

PA tag NZ-1	Character	Application	Ref	Gene cloning	Company
anti-PA tag mAb （NZ-1; rat IgG2a, lambda）	PAtag (GVAMPGAEDDVV；12 amino acid); trademark: No. 5671624; from AMED・PDIS project	Purification, IP, IHC, WB, FACS	PEP2014; JCS2016 PS2019; AC2021 Sci2022; PSSJ; Wako	○	in preparation
anti-PA tag mAb （NZ-27; human IgG1, lambda）	PAtag (GVAMPGAEDDVV；12 amino acid); trademark: No. 5671624; from AMED・PDIS project	Purification, IP, IHC, WB, FACS	JBC2023	○	in preparation
anti-PA14 tag mAb （NZ-1；rat IgG2a, lambda）	PA14 tag (EGGVAMPGAEDDVV); from AMED・SentanBio	Purification, IP, IHC, WB, FACS	PA14 tag system hGH-fusion Fab	○	in preparation
anti-PA16 tag mAb （NZ-1；rat IgG2a, lambda）	PA16 tag（GLEGGVAMPGAEDDVV）; from AMED・SentanBio	Purification, IP, IHC, WB, FACS	C44Mab5; PMab202; PMab210; PMab213; PMab219; PMab233	○	in preparation
MAP tag PMab-1	Character	Application	Ref	Gene cloning	Company
anti-MAP tag mAb （PMab-1；rat IgG2a, kappa）--> PAtag	MAPtag (GDGMVPPGIEDK；12 amino acids); trademark: No. 5988384; from AMED・KakushinBio; press release	Purification, IP, IHC, WB, FACS	MAB2016 BBREP2018 JB2020	○	AA; abcam; Nov; Merck; BioLegend in preparation
anti-MAP16 tag mAb （PMab-1；rat IgG2a, kappa）	MAP16 tag (PGTGDGMVPPGIEDKI；16 amino acids); from AMED・Tousa	Purification, IP, IHC, WB, FACS	PMab-235 PMab-44_goat	○	in preparation
RAP tag PMab-2	Character	Application	Ref	Gene cloning	Company
anti-RAP tag mAb (PMab-2；mouse IgG1, kappa)--> PAtag	RAP tag (DMVNPGLEDRIE; 12 amino acids); from AMED・KakushinBio	Purification, IP, IHC, WB, FACS	MAB2017 FPS2020 PP2021	○	AA; abcam Merck; BioLegend
anti-RAP14 tag mAb（double tag） (PMab-2; LpMab-7)	RAP14 tag（DMVNPGLEDRIEDL; 14 amino acids）; from AMED・Tousa	Purification, IP, IHC, WB, FACS	PMab44; PMab256; PDF; PMab253	○
anti-RAP16 tag mAb （PMab-2；mouse IgG1, kappa）	RAP16 (GPGDDMVNPGLEDRIE; 16 amino acids); from AMED・SentanBio	Purification, IP, IHC, WB, FACS	PMab-225_alpaca PMab-225_epitope PMab-44_alpaca	○
RIEDL tag LpMab-7	Character	Application	Ref	Gene cloning	Company
anti-RIEDL tagmAb (LpMab-7；mouse IgG1, kappa)-->PAtag	RIEDLtag (RIEDL; 5 amino acids): from AMED・SentanBio	Purification, IP, IHC, WB, FACS	RIEDL; PMab237 (1); PMab237 (2); C44-5; C44-46; E134; E51	○	abcam
MBP tag TMab-2	Character	Application	Ref	Gene cloning	Company
anti-MBP tag mAb （TMab-2；rat IgG2b, kappa）	specific for maltose-binding protein	IHC, WB	PubMed	○
anti-MBP tag mAb （YM-2；rat IgG2b, kappa）	specific for maltose-binding protein	IHC, WB	PubMed	○	BioLegend
BAP tag PMab-44	Character	Application	Ref	Gene cloning	Company
anti-BAP tagmAb (PMab-44；mouse IgG1, kappa)--> PAtag	BAP tag（EKTTLGVEDYTTTPAA; 16 amino acids); from AMED・BINDS・SentanBio	Purification, IP, IHC, WB, FACS	PMab247 PMab241	○	Zenogen
LP tag LpMab-17	Character	Application	Ref	Gene cloning	Company
anti-LP tag mAb (LpMab-17；mouse IgG1, kappa)-->PAtag	LPタグ(NSVTGIRIEDLPTSES; 16 amino acids); from AMED・BINDS・SentanBio	Purification, IP, IHC, WB, FACS	PMab52 PMab231	○	BD Merck
His tag HisMab-1	Character	Application	Ref	Gene cloning	Company
anti-His tag (HisMab-1;mouse IgG2b, kappa)-->PAtag	His tag (HHHH; 4 amino acids); from AMED・SentanBio	Purification, IP, IHC, WB, FACS	C20Mab60 Rituximab C20Mab11	○
anti-His tag; (HisMab-1-hG1；human IgG1, kappa)	His tag (HHHH; 4 amino acids); from AMED・SentanBio	Purification, IP, IHC, WB, FACS		○

　Back to list



＜Chemokine receptor＞

mouse CCR1 （CD191）	Character	Application	Ref	Gene cloning	Company
anti-mouse CCR1 mAb	in preparation	FACS
mouse CCR2 （CD192）	Character	Application	Ref	Gene cloning	Company
anti-mouse CCR2 mAb（C2Mab-6；rat IgG1, kappa）	specific for mouse CCR2; peptide immunization --> anti-human CCR2	FACS, WB, ICC	C2Mab-6 epitope	○	in preparation
mouse CCR3 （CD193）	Character	Application	Ref	Gene cloning	Company
anti-mouse CCR3 mAb（C3Mab-2；rat IgG2b, kappa）	specific for mouse CCR3; established by CBIS method	FACS	C3Mab-2 ICC	○
anti-mouse CCR3 mAb（C3Mab-3；rat IgG2a, kappa）	specifc mouse CCR3; established by CBIS method	FACS	C3Mab-3 epitope	○
anti-mouse CCR3 mAb（C3Mab-4；rat IgG2a, kappa）	specific mouse CCR3; established by CBIS method	FACS	epitope	○	in preparation
anti-mouse CCR3 mAb（C3Mab-6；rat IgG1, kappa）	specific mouse CCR3; peptide immunization	FACS	C3Mab-6 epitope	○	in preparation
anti-mouse CCR3 mAb（C3Mab-7；rat IgG1, kappa）	specific mouse CCR3; peptide immunization	FACS	C3Mab-7 epitope-1 epitope-2	○	in preparation
mouse CCR4 （CD194）	Character	Application	Ref	Gene cloning	Company
anti-mouse CCR4 mAb（C4Mab-1；rat IgG1, kappa）	specific for mouse CCR4; peptide immunization	FACS	C4Mab-1 epitope	○
mouse CCR5 （CD195）	Character	Application	Ref	Gene cloning	Company
anti-mouse CCR5 mAb（C5Mab-1; rat IgM, kappa）	specific for CCR5	FACS
mouse CCR6 （CD196）	Character	Application	Ref	Gene cloning	Company
anti-mouse CCR6 mAb（C6Mab-9；rat IgG1, kappa）	specific for mouse CCR6; peptide immunization --> anti-human CCR6	FACS		○	in preparation
anti-mouse CCR6 mAb（C6Mab-13；rat IgG1, kappa）	specific for mouse CCR6; peptide immunization	FACS	C6Mab-13 epitope	○
mouse CCR7 （CD197）	Character	Application	Ref	Gene cloning	Company
anti-mouse CCR7 mAb (C7Mab-1; rat IgM, kappa)	specific for mouse CCR7 （ref: BioLegend）	FACS
mouse CCR8 （CD198）	Character	Application	Ref	Gene cloning	Company
anti-mouse CCR8 mAb（C8Mab-1； rat IgG2a, kappa）	specific mouse CCR8; established by CBIS method	FACS, ICC	C8Mab-1	○
anti-mouse CCR8 mAb（C8Mab-2； rat IgG2b, kappa）	specific mouse CCR8; established by CBIS method （ref: Shionogi）（ref: BioLegend）	FACS, ICC	C8Mab-2 ICC	○	Merck
anti-mouse CCR8 mAb（C8Mab-3； rat IgG1, kappa）	specific mouse CCR8; established by CBIS method	FACS, ICC	C8Mab-3	○
mouse CCR8 (mouse IgG2a)	Character	Application	Ref	Gene cloning	Company
anti-mouse CCR8 mAb (C8Mab-2-mG2a)	specific mouse CCR8; established by CBIS method	FACS, ICC		○
mouse CCR9 （CD199）	Character	Application	Ref	Gene cloning	Company
anti-mouse CCR9 mAb（C9Mab-24；rat IgG2a, kappa）	specific for mouse CCR9; peptide immunization --> anti-human CCR9	FACS、WB	C9Mab-24 epitope	○
mouse CCR10	Character	Application	Ref	Gene cloning	Company
anti-mouse CCR10 mAb	in preparation	FACS
mouse CCR11	Character	Application	Ref	Gene cloning	Company
anti-mouse CCR11 mAb	in preparation	FACS
mouse CXCR1 （CD181）	Character	Application	Ref	Gene cloning	Company
anti-mouse CXCR1 mAb	in preparation	FACS
mouse CXCR2 （CD182）	Character	Application	Ref	Gene cloning	Company
anti-mouse CXCR2 mAb	in preparation	FACS
mouse CXCR3 （CD183）	Character	Application	Ref	Gene cloning	Company
anti-mouse CXCR3 mAb (Cx3Mab-1; rat IgG2b, kappa）	specific for mouse CXCR3	FACS
anti-mouse CXCR3 mAb (Cx3Mab-2; rat IgG2b, kappa）	specific for mouse CXCR3	FACS
anti-mouse CXCR3 mAb (Cx3Mab-3; rat Ig）	specific for mouse CXCR3	FACS
anti-mouse CXCR3 mAb (Cx3Mab-4; rat IgG1, kappa）	specific for mouse CXCR3	FACS
anti-mouse CXCR3 mAb (Cx3Mab-5; rat IgG2c, kappa）	specific for mouse CXCR3	FACS
anti-mouse CXCR3 mAb (Cx3Mab-6; rat IgG2b, kappa）	specific for mouse CXCR3	FACS
mouse CXCR4 （CD184）	Character	Application	Ref	Gene cloning	Company
anti-mouse CXCR4 mAb	in preparation ref: BD；BioLegend	FACS
mouse CXCR5 （CD185）	Character	Application	Ref	Gene cloning	Company
anti-mouse CXCR5 mAb (Cx5Mab-1; rat IgM, kappa)	specific for mouse CXCR5	FACS
mouse CXCR6 （CD186）	Character	Application	Ref	Gene cloning	Company
anti-mouse CXCR6 mAb(CX6Mab-1; rat IgG1, kappa)	specific for mouse CXCR6; peptide immunization	FACS, WB	CX6Mab-1 epitope-1 epitope-2	○	in preparation
anti-mouse CXCR6 mAb(CX6Mab-5; rat IgG1, kappa)	specific for mouse CXCR6; peptide immunization	FACS, WB		○	in preparation
mouse CXCR7 (CD187)	Character	Application	Ref	Gene cloning	Company
anti-mouse CXCR7 mAb	in preparation	FACS
mouse XCR1	Character	Application	Ref	Gene cloning	Company
anti-mXCR1 mAb	in preparation	FACS
mouse CX3CR1	Character	Application	Ref	Gene cloning	Company
anti-mouse CX3CR1 mAb	in preparation	FACS

Back to list

human CCR2 （CD192）	Character	Application	Ref	Gene cloning	Company
anti-hCCR2 mAb (C2Mab-9；mouse IgG1, kappa)	specific for human CCR2; expressed in U937 or NK cell; peptide immunization --> anti-mouse CCR2	FACS, ICC	C2Mab-9 epitope	○
human CCR6 （CD196）	Character	Application	Ref	Gene cloning	Company
anti-hCCR6 mAb (C6Mab-19；mouse IgG1, kappa)	specific for human CCR6; expressed in HepG2 or HuH-7; peptide immunization --> anti-mouse CCR6	FACS, IHC, ELISA	C6Mab-19
human CCR9 （CD199）	Character	Application	Ref	Gene cloning	Company
anti-hCCR9 mAb (C9Mab-1；mouse IgG1, kappa)	specific for human CCR9; developmed by CBIS method; expressed in MOLT-4 (acute T lymphoblastic leukemia) --> anti-mouse CCR9	FACS	C9Mab-1; epitope ICC	○	BD; exbio Novus Thermo
anti-hCCR9 mAb (C9Mab-6；mouse IgG1, kappa）	specific for human CCR9; established by CBIS method; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		○
anti-hCCR9 mAb (C9Mab-8；mouse IgG3, kappa）	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		○
anti-hCCR9 mAb (C9Mab-9；mouse IgG3, kappa）	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		○
anti-hCCR9 mAb (C9Mab-10；mouse IgG3, kappa）	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		○
anti-hCCR9 mAb (C9Mab-11；mouse IgG2a, kappa）	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS、WB	C9Mab-11 epitope	○
anti-hCCR9 mAb (C9Mab-12；mouse IgG1, kappa）	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		○
anti-hCCR9 mAb (C9Mab-13；mouse IgG2a, kappa）	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		○
anti-hCCR9 mAb (C9Mab-14；mouse IgG1, kappa）	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		○
anti-hCCR9 mAb (C9Mab-1016； mouse IgG1, kappa）	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		○	SunRock
anti-hCCR9 mAb (C9Mab-17；mouse IgG2b, kappa）	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		○
anti-hCCR9 mAb (C9Mab-18；mouse IgG3, kappa）	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		○
anti-hCCR9 mAb (C9Mab-1019； mouse IgG1, kappa）	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		○	SunRock
anti-hCCR9 mAb (C9Mab-21；mouse IgG3, kappa）	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		○
human XCR1	Character	Application	Ref	Gene cloning	Company
anti-hXCR1 mAb (X1Mab-4；mouse IgG1, kappa）	specific for human XCR1; established by peptide immunization	FACS		○
anti-hXCR1 mAb (X1Mab-29；mouse IgM, kappa）	specific for human XCR1; established by peptide immunization	FACS		○
anti-hXCR1 mAb (X1Mab-47；mouse IgM, kappa）	specific for human XCR1; established by CBIS (immunization of MDA-MB-157/PA-hXCR1)	FACS

Back to list





＜EGFR/HER2/HER3/HER4＞

mouse EGFR	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb; EMab-300 (rat IgG1, kappa）	specific for mouse EGFR domain-I	FACS	EMab-300	○	in preparation
anti-mouse/human EGFR mAb; EMab-88 (mouse IgG1, kappa）	specific for EGFR; EMab-88 was developed against human EGFR; crossreacts with mouse EGFR (domain-III)	FACS	data	○
human EGFR domain-I	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb （EMab-23；mouse IgG1, kappa）	specific for EGFR; crossreacts with dog EGFR; reacts with domain-I	FACS		○
anti-EGFR mAb （EMab-78；mouse IgG2b, kappa）	specific for EGFR; reacts with domain-I	FACS		○
anti-EGFR mAb （EMab-129；mouse IgG1, lambda）	specific for EGFR; reacts with domain-I	FACS		○
human EGFR domain-II	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb （EMab-19；mouse IgG2a, kappa）	specific for EGFR; crossreacts with dog EGFR; reacts with domain-II	FACS		○
anti-EGFR mAb （EMab-33；mouse IgG1, kappa）	specific for EGFR; reacts with domain-II	FACS		○
anti-EGFR mAb （EMab-57；mouse IgG1, kappa）	specific for EGFR; crossreacts with dog EGFR; reacts with domain-II	FACS		○
anti-EGFR mAb （EMab-76；mouse IgG1, kappa）	specific for EGFR; reacts with domain-II	FACS		○
human EGFR domain-III	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb （EMab-134；mouse IgG1, kappa）	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, WB, IHC	EMab-134 epitope-1 epitope-2	○	abcam BD
anti-EGFR mAb （134-mG2a；mouse IgG2a, kappa）	mouse IgG2a version of EMab-134; specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, WB, IHC, ADCC/CDC, antitumor activities	134-mG2a	○
anti-EGFR mAb （EMab-51；mouse IgG1, kappa）	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, WB, IHC	EMab-51 epitope	○
anti-EGFR mAb （51-mG2a；mouse IgG2a, kappa）	mouse IgG2a version of EMab-51specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, WB, IHC, ADCC, CDC, antitumor activities		○
anti-EGFR mAb （51-mG2a-f；mouse IgG2a, kappa）	core fucose-deficient mouse IgG2a version of EMab-51; specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, WB, IHC, ADCC, CDC, antitumor activities		○
anti-EGFR mAb （EMab-17；mouse IgG2a, kappa）	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, ADCC/CDC, antitumor activities	EMab-17 metastasis	○
anti-EGFR mAb （recEMab-17-f；mouse IgG2a）	core fucose-deficient mouse IgG2a version of EMab-17; specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, ADCC/CDC, antitumor activities		○
anti-EGFR mAb （EMab-1；mouse IgG1, kappa）	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS		○
anti-EGFR mAb （EMab-32；mouse IgG2a, kappa）	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS		○
anti-EGFR mAb （EMab-114；mouse IgG2b, kappa）	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS		○
anti-EGFR mAb （EMab-125；mouse IgG1, kappa）	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, WB		○
anti-EGFR mAb （EMab-139；mouse IgG1, kappa）	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, WB		○
anti-EGFR mAb （EMab-151；mouse IgG2b, kappa）	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS		○
human EGFR domain-IV	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb （EMab-95；mouse IgG1, kappa）	specific for EGFR; reacts with domain-IV	FACS		○
anti-EGFR mAb （EMab-110；mouse IgG1, kappa）	specific for EGFR; reacts with domain-IV	FACS		○
dog EGFR	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb （134-mG2a-f；mouse IgG2a）	core fucose-deficient mouse IgG2a version of EMab-134; reacts with domain-III	FACS, WB, IHC, ADCC, CDC, antitumor activities	CHO/dEGFR OS; Fibro Mammary	○
anti-EGFR mAb （E134Bf；canine IgGB, kappa）	core fucose-deficient canine IgGB version of EMab-134; specific for EGFR	FACS, WB, IHC, ADCC, CDC, antitumor activities	Mammary Fibro & Osteo	○
bispecific	Character	Application	Ref	Gene cloning	Company
anti-dog EGFR-dog HER2 mAb （E134B-H77scFv-f）	bispecific mAb for EGFR and HER2	FACS, WB, IHC, ADCC, CDC, antitumor activities	E134B-H77scFv-f	○
anti-EGFR-PDPN mAb （E134-NZ1scFv-mG2a-f）	bispecific mAb for EGFR and PDPN	FACS, WB, IHC, ADCC, CDC, antitumor activities		○

Back to list

mouse HER2 （CD340）	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb （H2Mab-300 ；rat IgG2b, kappa）	specific for mouse HER2 does not cross-react with dog HER2	FACS	H2Mab-300	○
anti-HER2 mAb （H2Mab-303 ；rat IgG2a, kappa）	specific for mouse HER2 does not cross-react with dog HER2	FACS		○	in preparation
anti-HER2 mAb （H2Mab-304 ；rat IgG1, kappa）	specific for mouse HER2 does not cross-react with dog HER2	FACS, WB	H2Mab-304	○	in preparation
anti-HER2 mAb （H2Mab-307 ；rat IgG2a, kappa）	specific for mouse HER2 does not cross-react with dog HER2	FACS		○	in preparation
anti-HER2 mAb （H2Mab-314 ；rat IgG1, kappa）	specific for mouse HER2 does not cross-react with dog HER2	FACS, WB		○
HER2 domain-I	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb （H2Mab-77；mouse IgG1, kappa）	specific for HER2; crossreacts with dog HER2; (参考：TNBC)	FACS, WB, IHC	H2Mab-77	○	BioLegnd
anti-HER2 mAb （H2Mab-77-mG2a-f；mouse IgG2a）	specific for HER2; crossreacts with dog HER2; (ref：TNBC)	FACS, WB, IHC	H2Mab-77-mG2a-f	○
anti-HER2 mAb （H2Mab-77-hG1；human IgG1）	specific for HER2; crossreacts with dog HER2; (ref：TNBC)	FACS, WB, IHC		○
anti-HER2 mAb （H2Mab-119；mouse IgG1, kappa）	specific for HER2; crossreacts with dog HER2	FACS, WB, IHC	H2Mab-119 PCT/JP2021/043538	○
anti-HER2 mAb （H2Mab-119-mG2a-f；mouse IgG2a）	specific for HER2; crossreacts with dog HER2	FACS, WB, IHC	in preparation	○
anti-HER2 mAb （H2Mab-119-hG1；human IgG1）	specific for HER2; crossreacts with dog HER2	FACS, WB, IHC		○
anti-HER2 mAb （H2Mab-139；mouse IgG1, kappa）	specific for HER2; crossreacts with dog HER2	FACS, WB, IHC	H2Mab-139	○	abcam
anti-HER2 mAb (H2Mab-139-mG2a;mouse IgG2a)	specific for HER2; crossreacts with dog HER2	FACS, WB, IHC		○
anti-HER2 mAb （H2Mab-139-mG2a-f；mouse IgG2a）	specific for HER2; crossreacts with dog HER2	FACS, WB, IHC	H2Mab-139-mG2a-f	○
HER2 domain-II	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb （H2Mab-32；mouse IgG1, kappa）	specific for HER2	FACS		ongoing
anti-HER2 mAb （H2Mab-133；mouse IgG1, kappa）	specific for HER2	FACS		ongoing
anti-HER2 mAb （H2Mab-193；mouse IgG1, kappa）	specific for HER2	FACS		ongoing
anti-HER2 mAb （H2Mab-215；mouse IgG1, kappa）	specific for HER2	FACS		ongoing
HER2 domain-III	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb （H2Mab-19；mouse IgG2b, kappa）	specific for HER2; crossreacts with mouse HER2 or dog HER2; domain-III	FACS, ADCC/CDC, antitumor activities	PC CRC GBM	○
anti-HER2 mAb （H2Mab-181；mouse IgG1, kappa）	specific for HER2; crossreacts with dog HER2; domain-III; epitope: p373ー392。	FACS, WB, IHC	H2Mab-181 epitope	○
HER2 domain-IV	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb （H2Mab-41；mouse IgG2b, kappa）	specific for HER2; crossreacts with dog HER2; domain-IV	FACS, antitumor activities	H2Mab-41 dogHER2	○
anti-HER2 mAb （trastuzumab； human IgG1,kappa）	specific for HER2	FACS	H2Mab-214	○
anti-HER2 mAb （tras-mG2a； mouse IgG2a,kappa）	mouse IgG2a-version of trastuzumab specific for HER2	FACS		○
anti-HER2 mAb （H77Bf；canine IgGB, kappa）	core fucose-deficient canine IgGB version of H2Mab-77	FACS, WB, IHC, ADCC/CDC, antitumor activities	H77Bf OS fibro	○

Back to list

HER3	Character	Application	Ref	Gene cloning	Company
anti HER3 mAb （H3Mab-17；mouse IgG2a, kappa）	specific for HER3	FACS, ADCC/CDC, antitumor activities	H3Mab-17	○	exbio

Back to list

HER4	Character	Application	Ref	Gene cloning	Company
anti-HER4 mAb (H4Mab-12~; mouse IgG)	specific for HER4	FACS

　Back to list



＜Immune checkpoint＞

KLRG1	Character	Application	Ref	Gene cloning	Company
anti-KLRG1 mAb （KLMab-1；mouse IgG1, kappa）	specific for human KLRG1	FACS、ICC	KLMab-1 ICC	○

Back to list

PD-L1	Character	Application	Ref	Gene cloning	Company
anti-PD-L1 mAb （L1Mab-13；mouse IgG1, kappa）	specific for human PD-L1	FACS, WB, IHC (cell), IHC (tissue), ELISA	L1Mab-13	○
anti-PD-L1 mAb （13-mG2a-f；mouse IgG2a, kappa）	specific for human PD-L1; core fucose-deficient IgG2a of L1Mab-13	FACS, WB, IHC (cell), IHC (tissue), ELISA, ADCC/CDC, antitumor activities	13-mG2a-f	○
dog PD-L1	Character	Application	Ref	Gene cloning	Company
anti-dog PD-L1 mAb （L1Mab-347；mouse IgG1, kappa）	specific for dog PD-L1 (extracellular domain)	FACS, IHC		○
anti-dog PD-L1 mAb （L1Mab-352； mouse IgG1, kappa）	specific for dog PD-L1 (intracellular domain)	ELISA, IHC	L1Mab-352	◯
anti-dog PD-L1 mAb （L1Mab-354； mouse IgG1, kappa）	specific for dog PD-L1 (intracellular domain)	ELISA, IHC	L1Mab-354	○

Back to list

PD-L2	Character	Application	Ref	Gene cloning	Company
anti-PD-L2 mAb （L2Mab-1；mouse IgG2b, kappa）	specific for PD-L2	FACS, WB, IHC (cell)		○

Back to list

TIGIT	Character	Application	Ref	Gene cloning	Company
anti-TIGIT mAb （TgMab-1；mouse IgG1, kappa）	specific for TIGIT	FACS KD: 6.7 x 10^-10		○
anti-TIGIT mAb （TgMab-2；mouse IgG1, kappa）	specific for TIGIT	FACS、WB、ICC KD: 3.5 x 10^-9	TgMab-2 ICC	○	BD

　Back to list





＜Monoclonal antibodies for the other membrane proteins＞

CD19	Character	Application	Ref	Gene cloning	Company
anti-CD19 mAb （C19Mab-1；mouse IgG1, kappa）	specific for CD19; CBIS method; LN229/CD19 immunization	FACS	C19Mab-1	○
anti-CD19 mAb (C19Mab-2;mouse IgG1,kappa)	specific for CD19; CBIS method; LN229/CD19 immunization	FACS		○
anti-CD19 mAb (humC19Mab-2;human IgG1,kappa)	humanized C19Mab-2	FACS		○
anti-CD19 mAb (humC19Mab-2 -scFv)	scFv of humanized C19Mab-2	FACS		○
anti-CD19 mAb （C19Mab-3；mouse IgG1, kappa）	specific for CD19; CBIS method; ectodomain of CD19 immunization	IHC,WB	C19Mab-3	○

Back to list

CD20	Character	Application	Ref	Gene cloning	Company
抗CD20 mAb （C20Mab-11；mouse IgM, kappa）	specific for CD20	FACS, WB, IHC	C20Mab-11 epitope	ongoing
抗CD20 mAb （C20Mab-60；mouse IgG2a, kappa）	specific for CD20; ref：rituximab	FACS, WB, IHC	C20Mab-60 epitope-1 epitope-2	ongoing	BioLegnd

listに戻る

CD39	Character	Application	Ref	Gene cloning	Company
anti-CD39 mAb （C39Mab-1；rat IgG2a, kappa）	specific for mouse CD39	FACS, WB	C39Mab-1	○	in preparation
anti-CD39 mAb （C39Mab-2；rat IgG2a, lambda）	specific for mouse CD39	FACS	C39Mab-2	○	in preparation

Back to list

CD44s	Character	Application	Ref	Gene cloning	Company
anti-CD44s mAb （C44Mab-5； mouse IgG1, kappa）	Specific for CD44s (CD44 standard)	IHC, FACS, WB	C44Mab-5 epitope	○	abcam BioLegnd
anti-CD44s mAb （5-mG2a-f； mouse IgG2a）	mouse IgG2a version of C44Mab-5; specific for CD44s (CD44 standard)。	IHC, FACS, ADCC, CDC, antitumor activities	5-mG2a-f	○
anti-CD44s mAb （C44Mab-46； mouse IgG1, kappa）	specific for CD44s (CD44 standard)	FACS, IHC, WB	C44Mab-46 epitope-1 epitope-2	○
anti-CD44s mAb (C44Mab-46-mG2a-f；mouse IgG2a)	mouse IgG2a version of C44Mab-46 specific for CD44s (CD44 standard)	IHC, FACS, WB		○

Back to list

CD44v3	Character	Application	Ref	Gene cloning	Company
anti-CD44v3 mAb （C44Mab-6； mouse IgG1, kappa）	specific for CD44v3 (oral cancer and colon cancer)	FACS, WB, IHC, ELISA	C44Mab-6(IJMS) FACS(CAS)	○	in preparation
anti-CD44v3 mAb （C44Mab-6-mG2a-f；mouse IgG2a）	IgG2a version of C44Mab-6	FACS, WB, IHC, ELISA	ongoing	ongoing
CD44v4	Character	Application	Ref	Gene cloning	Company
anti-CD44v4 mAb （C44Mab-108； mouse IgG1, kappa）	specific for CD44v4 (oral cancer)	WB, IHC, ELISA	C44Mab-108 (CIMB)	○	in preparation
CD44v5	Character	Application	Ref	Gene cloning	Company
anti-CD44v5 mAb （C44Mab-3； mouse IgG1, kappa）	specific for CD44v5 (pancreatic cancer)	FACS, WB, IHC, ELISA	C44Mab-3 (antibodies)	○	in preparation
anti-CD44v5 mAb （C44Mab-3-mG2a-f；mouse IgG2a）	IgG2a version of C44Mab-3	FACS, WB, IHC, ELISA	ongoing	ongoing
CD44v6	Character	Application	Ref	Gene cloning	Company
anti-CD44v6 mAb （C44Mab-9； mouse IgG1, kappa）	specific for CD44v6 (colon cancer)	FACS, WB, IHC, ELISA	C44Mab-9 (IJMS)	○	in preparation
anti-CD44v6 mAb （C44Mab-9-mG2a-f；mouse IgG2a）	IgG2a version of C44Mab-9	FACS, WB, IHC, ELISA	ongoing	ongoing
anti-CD44v6 mAb （bivatuzumab； human IgG1, kappa）	specific for CD44v6	ref		○
CD44v7	Character	Application	Ref	Gene cloning	Company
anti-CD44v7/v8 mAb （C44Mab-34； mouse IgG1, kappa）	specific for CD44v7/v8 (oral cancer)	FACS, WB, IHC, ELISA	C44Mab-34 (Biomedicines)	○
anti-CD44v7/v8 mAb （C44Mab-34-mG2a-f；mouse IgG2a）	mouse IgG2a version of C44Mab-34	FACS, WB, IHC, ELISA	ongoing	ongoing
CD44v8	Character	Application	Ref	Gene cloning	Company
anti-CD44v8 mAb （C44Mab-94； mouse IgG1, kappa）	specific for CD44v8 (gastric cancer)	FACS, WB, IHC, ELISA	C44Mab-94 (antibodies)	○
anti-CD44v8 mAb （C44Mab-94-mG2a-f；mouse IgG2a）	mouse IgG2a version of C44Mab-94	FACS, WB, IHC, ELISA	ongoing	ongoing
CD44v9	Character	Application	Ref	Gene cloning	Company
anti-CD44v9 mAb （C44Mab-1； mouse IgG1, kappa）	specific for CD44v9 (colon cancer)	FACS, WB, IHC, ELISA	C44Mab-1(CIMB) FACS(CAS)	○
anti-CD44v9 mAb （C44Mab-1-mG2a-f；mouse IgG2a）	mouse IgG2a version of C44Mab-1	FACS, WB, IHC, ELISA	ongoing	ongoing
CD44v10	Character	Application	Ref	Gene cloning	Company
anti-CD44v10 mAb （C44Mab-18； mouse IgM, kappa）	specific for CD44v10 (oral cancer)	FACS, WB, IHC, ELISA	C44Mab-18 (CIMB)	○
anti-CD44v10 mAb （C44Mab-18-mG1； mouse IgG1, kappa）	mouse IgG1 version of CD44v10	FACS, WB, IHC, ELISA		○
anti-CD44v10 mAb （C44Mab-18-mG2a-f；mouse IgG2a）	mouse IgG2a version of C44Mab-18	FACS, WB, IHC, ELISA	ongoing	○

Back to list

CD133	Character	Application	Ref	Gene cloning	Company
anti-CD133 mAb （CMab-43；mouse IgG2a, kappa）	specific for CD133	FACS, WB, IHC, ADCC/CDC, antitumor activities	CMab-43 in vivo	○	abcam BD
anti-CD133 mAb （CMab-44；mouse IgG1, kappa）	specific for CD133; detects AML	FACS, WB		○	in preparation

Back to list

CD271	Character	Application	Ref	Gene cloning	Company
anti-CD271抗体 （G4B1；mouse IgG2a, kappa）	cancer-specific mAb for CD271	FACS, WB, IHC	anti-CD271 mAb	○	in preparation

Back to list

CD276	Character	Application	Ref	Gene cloning	Company
anti-CD276 mAb	specific for CD276

Back to list

EpCAM (CD326)	Character	Application	Ref	Gene cloning	Company
anti-EpCAM mAb （EpMab-16；mouse IgG2a, kappa）	specific for EpCAM	FACS, WB, IHC	EpMab-16 (1) EpMab-16 (2)	○	merck
anti-EpCAM mAb （EpMab-37；mouse IgG1, kappa）	specific for EpCAM	FACS, WB, IHC	EpMab-37 epitope	○
anti-EpCAM mAb （EpMab-37-mG2a-f；mouse IgG2a）	specific for EpCAM	FACS, WB, IHC, ADCC, CDC, antitumor activities	EpMab-37 (1) EpMab-37 (2)	○	in preparation
anti-EpCAM mAb （EpMab-3；mouse IgG1, kappa）	specific for EpCAM	FACS		○

Back to list

TROP2	Character	Application	Ref	Gene cloning	Company
anti-TROP2 mAb （TrMab-6；mouse IgG2b, kappa）	specific for human TROP2; (ref：TNBC)	IHC, WB, FACS	TrMab-6 MCF7 TNBC	○	exbio
anti-TROP2 mAb （TrMab-29；mouse IgG1, kappa）	specific for human TROP2	IHC, WB, FACS	TrMab-29	○	merck
anti-TROP2 mAb （Datopotamab；humanized IgG1, kappa）	Humanized mAb for DS-1062/Dato-DXd (Daiichi-Sankyo)	FACS		○
anti-TROP2 mAb （Sacituzumab；humanized IgG1, kappa）	Humanized mAb （Sacituzumab govitecan；Trodelvy）	FACS		○

Back to list

HGF	Character	Application	Ref	Gene cloning	Company
anti-HGF mAb （t8E4；mouse IgG1, kappa）	specific for active HGF	WB, IHC	SREP IJMS	○	Merck
anti-HGF mAb （t5A11；mouse IgG1, kappa）	specific for HGF	WB, IHC	SREP IJMS	○
anti-HGF mAb （t1E4；mouse IgG2b, kappa）	specific for HGF	neutralization	SREP	○

　Back to list

Podocalyxin	Character	Application	Ref	Gene cloning	Company
anti-PODXL mAb （PcMab-6；mouse IgG1, kappa）	anti-PODXL CasMab	FACS	patent	○
anti-PODXL mAb （PcMab-47；mouse IgG1, kappa）	specific for human PODXL	FACS, WB, IHC	PcMab-47 IHC_OSCC epitope	○	abcam exbio
anti-PODXL mAb （47-mG2a；mouse IgG2a, kappa）	IgG2a version of PcMab-47; specific for human PODXL	FACS, WB, IHC; ADCC/CDC, antitumor activities	47-mG2a IHC_LK IHC_EC	○
anti-PODXL mAb （47-mG2a-f；mouse IgG2a, kappa）	core fucose-deficient IgG2a version of PcMab-47; specific for human PODXL	FACS, WB, IHC; ADCC/CDC, antitumor activities	47-mG2a-f	○
anti-PODXL mAb （chPcMab-47；human IgG1）	specific for human PODXL	FACS, WB, IHC	chPcMab-47	○
anti-PODXL mAb （PcMab-60；mouse IgM, kappa）	anti-PODXL CasMab	FACS	PcMab-60 epitope patent	○
anti-PODXL mAb （60-mG2a；mouse IgG2a, kappa）	anti-PODXL CasMab; IgG2a version of PcMab-60	FACS, ADCC/CDC	60-mG2a	○
anti-PODXL mAb （60-mG2a-f；mouse IgG2a, kappa）	anti-PODXL CasMab, core fucose-deficient IgG2a version of PcMab-60	FACS, ADCC/CDC, antitumor activities	60-mG2a-f	○

Back to list

human podoplanin	Character	Application	Ref	Gene cloning	Company
anti-hPDPN mAb（NZ-1; rat IgG2a）	specific for human PDPN; the other clones: NZ-1.2( Sigma, Merck, MBL, Novus, Zenogen, Wako); NZ-1.3(Thermo), NC-08 （BioLegend）	IP、IHC, WB, FACS (Review; patent)	NZ-1; KD NZ-1.2 CTC; PIT	○
anti-human PDPN mAb（NZ-8; human IgG1）	specific for human PDPN; rat-human chimeric mAb originated from NZ-1	IP、IHC, WB, FACS	NZ-8	○
anti-human PDPN mAb（NZ-12; human IgG1）	specific for human PDPN; rat-human chimeric mAb originated from NZ-1	IP、IHC, WB, FACS	NZ-12 RIT	○
anti-human PDPN mAb（NZ-16; human IgG1）	specific for human PDPN; rat-human chimeric mAb originated from NZ-1	IP、IHC, WB, FACS	RIT	○
anti-human PDPN mAb（NZ-27; human IgG1）	specific for human PDPN; humanized mAb originated from NZ-1	IP、IHC, WB, FACS	NZ-27 CAR-T	○
anti-hPDPN mAb (LpMab-2；mouse IgG1, kappa)	CasMab	IHC, WB, FACS	Cells2022 LpMab-2 patent	○
anti-hPDPN mAb (LpMab-3；mouse IgG1, kappa)	specific for human PDPN; epitope: Thr76	IHC, WB, FACS	LpMab-3 epitope Structure	○	MCP
anti-hPDPN mAb (LpMab-7；mouse IgG1, kappa)	specific for human PDPN	IHC, WB, FACS	LpMab-7 OS epitope	○	abcam MCP zenogen
anti-human PDPN mAb（chLpMab-7；human IgG1）	specific for human PDPN; mouse-human chimeric mAb originated from LpMab-7	IHC, WB, FACS	chLpMab-7	○
anti-hPDPN mAb (LpMab-9；mouse IgG1, kappa)	specific for human PDPN; epitope: Thr25	WB, FACS	LpMab-9 epitope	○	MCP
anti-hPDPN mAb (LpMab-10；mouse IgG3, kappa)	specific for human PDPN; epitope: PLAG1 Thr34	IHC, WB, FACS	LpMab-10	○
anti-hPDPN mAb (LpMab-12；mouse IgG1, kappa)	specific for human PDPN; epitope: PLAG3 Thr52	IHC, WB, FACS	LpMab-12	○	CST Merck Hycult MCP zenogen
anti-hPDPN mAb (LpMab-13；mouse IgG1, kappa)	specific for human PDPN; epitope: PLAG2-3	IHC, WB, FACS	LpMab-13	○	Merck Hycult
anti-hPDPN mAb (LpMab-16；mouse IgG1, kappa)	specific for human PDPN	IHC, WB, FACS	patent 2018-123699	○
anti-hPDPN mAb (LpMab-17；mouse IgG1, kappa)	specific for human PDPN	IHC, WB, FACS press release	LpMab-17	○	BD Merck Hycult
anti-hPDPN mAb (LpMab-19；mouse IgG2b, kappa)	specific for human PDPN; epitope: Thr76	IHC, WB, FACS, ADCC/CDC	LpMab-19	○	Merck
anti-hPDPN mAb (LpMab-21；mouse IgG2a, kappa)	specific for human PDPN; epitope: Thr76	IHC, WB, FACS, ADCC/CDC press release	Cells2022 LpMab-21 in vivo	○	Merck BioLegend MCP
anti-hPDPN mAb (LpMab-23；mouse IgG1, kappa)	CasMab	IHC, WB, FACS	LpMab-23 IHC patent	○	BD exbio zenogen

Back to list

mouse podoplanin	Character	Application	Ref	Gene cloning	Company
anti mouse PDPN mAb (PMab-1；rat IgG2a, kappa)	specific for mouse PDPN --> anti-human PDPN	IHC, WB, FACS	PMab-1 PMab-1_LEC epitope	○	abcam; MBL; Nov; Mer; BioL
anti-mouse PDPN mAb (mPMab-1;mouse IgG2a,kappa)	specific for mouse PDPN	IHC, WB, FACS	mPMab-1	○
anti-mouse PDPN mAb (PMab-1-mG2a-f;mouse IgG2a,kappa)	specific for mouse PDPN	IHC, WB, FACS		○
rat PDPN	Character	Application	Ref	Gene cloning	Company
anti-rat PDPN mAb （PMab-2；mouse IgG1, kappa）	specific for rat PDPN	IHC, WB, FACS	PMab-2 PMab-2_epitope	○	abcam Merck BioLegend
rabbit PDPN	Character	Application	Ref	Gene cloning	Company
anti-rabbit PDPN mAb （PMab-32；mouse IgG1, kappa）	specific for rabbit PDPN	IHC, WB, FACS	PMab-32 epitope
dog PDPN	Character	Application	Ref	Gene cloning	Company
anti-dog PDPN mAb （PMab-38；mouse IgG1, kappa）	specific for dog PDPN	IHC, WB, FACS	PMab-38; SCC melanoma epitope	○	zenogen Wako
anti-dog PDPN mAb （P38Bf；dog IgGB, kappa）	core fucose-deficient type B of PMab-38	IHC, WB, FACS	P38Bf P38B_in vivo ADC	○
anti-dog PDPN mAb （PMab-48；mouse IgG1, kappa）	specific for dog PDPN	IHC, WB, FACS	PMab-48 epitope	○	zenogen
bovine PDPN	Character	Application	Ref	Gene cloning	Company
anti-bovPDPN mAb (PMab-44；mouse IgG1, kappa)	specific for bovine PDPN	IHC, WB, FACS	PMab-44; epitope goat; sheep; alpaca	○	zenogen
cat PDPN	Character	Application	Ref	Gene cloning	Company
anti-cat PDPN mAb （PMab-52；mouse IgM, kappa）	specific for cat PDPN	IHC, WB, FACS	PMab-52; epitope IHC-1; IHC-2 tiger PDPN	○	zenogen
tiger PDPN	Character	Application	Ref	Gene cloning	Company
anti-tiger PDPN mAb （PMab-231；mouse IgG2a, kappa）	specific for tiger PDPN	IHC, WB, FACS	PMab-231 epitope lion PDPN	○	zenogen
horse PDPN	Character	Application	Ref	Gene cloning	Company
anti-horse PDPN mAb （PMab-219；mouse IgG2a, kappa）	specific for horse PDPN	WB, FACS, IHC	PMab-219 epitope PMab-219_epitope	○	zenogen
anti-horse PDPN mAb （PMab-202；mouse IgG1, kappa）	specific for horse PDPN	WB, FACS	PMab-202 epitope	○	zenogen
pig PDPN	Character	Application	Ref	Gene cloning	Company
anti-pig PDPN mAb （PMab-213；mouse IgG2b, kappa）	specific for pig PDPN	WB, FACS, IHC	PMab-213 epitope LEC	○	zenogen
anti-pig PDPN mAb （PMab-210；mouse IgG1, kappa）	specific for pig PDPN	WB, FACS, IHC	PMab-210 epitope	○	zenogen
goat PDPN	Character	Application	Ref	Gene cloning	Company
anti-goat PDPN mAb (PMab-235；mouse IgG1, kappa)	specific for goat PDPN	IHC, WB, FACS	PMab-235 epitope	○	zenogen
alpaca PDPN	Character	Application	Ref	Gene cloning	Company
anti-aPDPN mAb (PMab-225；mouse IgG2b, kappa)	specific for alpaca PDPN	IHC, WB, FACS	PMab-225 epitope	○	zenogen
Tasmanian devil PDPN	Character	Application	Ref	Gene cloning	Company
anti-TasPDPN PDPN (PMab-233；mouse IgG1, kappa)	specific for Tasmanian devil PDPN	IHC, WB, FACS	PMab-233 epitope	○	zenogen
bear PDPN	Character	Application	Ref	Gene cloning	Company
anti-bear PDPN mAb （PMab-241；mouse IgG2b, kappa）	specific for bear PDPN	IHC, WB, FACS	PMab-241 epitope
anti-bear PDPN mAb （PMab-247；mouse IgG1, kappa）	specific for bear PDPN	IHC, WB, FACS	PMab-247 IHC epitope	○	zenogen
whale PDPN	Character	Application	Ref	Gene cloning	Company
anti-whale PDPN mAb （PMab-237；mouse IgG1, kappa）	specific for whale PDPN	IHC, WB, FACS	PMab-237 IHC epitope	○	zenogen
sheep PDPN	Character	Application	Ref	Gene cloning	Company
anti-sheep PDPN mAb （PMab-256；mouse IgG1, kappa）	specific for sheep PDPN	IHC, WB, FACS	PMab-256 epitope	○	zenogen
anti-sheep PDPN mAb （PMab-253；mouse IgM, kappa）	specific for sheept PDPN	IHC, WB, FACS	PMab-253	○
anti-sheep PDPN mAb （PMab-260；mouse IgM, kappa）	specific for sheep PDPN	IHC, WB, FACS	PMab-260	○
sea lion PDPN	Character	Application	Ref	Gene cloning	Company
anti-seaPDPN mAb (PMab-269；mouse IgG1, kappa)	specific for sea lion PDPN	IHC, WB, FACS	PMab-269 epitope Steller Sea Lion	○
elephant PDPN	Character	Application	Ref	Gene cloning	Company
anti-elePDPN mAb (PMab-265；mouse IgM, kappa）	specific for elephant PDPN	FACS	PMab-265
anti-elePDPN mAb (PMab-295；mouse IgG1, kappa）	specific for elephant PDPN	FACS, WB, IHC	PMab-295 epitope	○	Ab.antibody
ferret PDPN	Character	Application	Ref	Gene cloning	Company
anti-ferret PDPN mAb （PMab-241；mouse IgG2b, kappa）	anti-bear PDPN mAb crossreacts with ferret PDPN	IHC, WB, FACS	PMab-241
anti-ferret PDPN mAb （PMab-292；mouse IgG1, kappa）	specific for ferret PDPN	IHC, WB, FACS	PMab-292	○	Ab.antibody
hamster PDPN	Character	Application	Ref	Gene cloning	Company
anti-hamPDPN mAb (PMab-281；mouse IgG3, kappa)	specific for hamster PDPN	FACS, IHC	PMab-281 epitope	○
anti-hamPDPN mAb (281-mG2a-f；mouse IgG2a, kappa)	specific for hamster PDPN; IgG2a version of PMab-281	FACS, IHC	PMab-281 epitope	○
giraffe PDPN	Character	Application	Ref	Gene cloning	Company
anti-girPDPN mAb (PMab-301；mouse IgG1, kappa)	specific for giraffe PDPN	FACS, WB, IHC
panda PDPN	Character	Application	Ref	Gene cloning	Company
anti-panPDPN mAb ()	specific for panda PDPN

　Back to list



＜細胞内タンパク質を標的とした抗体シリーズ＞

ATRX	Character	Application	Ref	Gene cloning	Company
anti-ATRX mAb （AMab-6；mouse IgG1, kappa）	specific for human ATRX	IHC, WB	AMab-6 AMab-6_epitope AMab-6_IHC	○	abcam

listに戻る

DGK	Character	Application	Ref	Gene cloning	Company
anti-DGKalpha mAb （DaMab-2；mouse IgG1, kappa）	specifi for DGKalpha	ICC	DaMab-2 epitope	○
anti-DGKalpha mAb （DaMab-8；mouse IgG1, kappa）	specific for DGKalpha	IHC	DaMab-8	○
anti-DGKalpha mAb （Da8mG2a； mouse IgG2a, kappa）	specific for DGKalpha	ICC, IHC		in preparation
anti-DGKgamma mAb （DgMab-6；mouse IgG1, kappa）	specific for DGKgamma	ICC	DgMab-6 PDF	○
anti-DGKzeta mAb （DzMab-1；rat IgG2b, kappa）	specific for DGKzeta	ICC	DzMab-1 epitope	○
anti-DGKzeta mAb （Dz1mG2a； mouse IgG2a, kappa）	specific for DGKzeta	ICC		in preparation
anti-DGKeta mAb （DhMab-1；mouse IgG2a, kappa）	specific for DGKeta	IHC	DhMab-1
anti-DGKeata mAb （DhMab-4；mouse IgG2b, kappa）	specific for DGKeta	IHC	DhMab-4 ICC
anti-DGKdelta mAb （DdMab-1；mouse IgG2a, kappa）	specific for DGKdeta	IHC	DdMab-1

　Back to list

IDH	Character	Application	Ref	Gene cloning	Company
anti-IDH1-R132H mAb (HMab-1; mouse IgG1, kappa)	specific for IDH1-R132H	IHC, WB	HMab-1	○	Merck MBL; IBL; Sigma
anti-IDH1-R132H mAb (HMab-2; mouse IgG1, kappa)	specific for IDH1-R132Hを	IHC, WB	HMab-2	○	abcam
anti-IDH1-R132S mAb (SMab-1; mouse IgG1, kappa)	specific for IDH1-R132S	IHC, WB	SMab-1	○	abcam IBL; MBL Merck_Sigma
anti-IDH1-R132G mAb (GMab-r1；rat IgG2a, kappa)	specific for IDH1-R132G	IHC, WB	GMab-r1		abcam MBL
anti-IDH2-R172K mAb (KMab-1；rat IgG2b, kappa)	specific for IDH2-R172K	IHC, WB	KMab-1		abcam MBL
anti-IDH2-R172M mAb (MMab-1；rat IgG2b, kappa)	specific for IDH2-R172M	IHC, WB	MMab-1		abcam MBL
anti-IDH2-R172W mAb (WMab-1；rat IgG2b, kappa)	specific for IDH2-R172W	IHC, WB	WMab-1		abcam MBL
anti-IDH2-R172S mAb (SMab-2；mouse IgG1, kappa)	specific for IDH2-R172S	IHC, WB	SMab-2		abcam
anti-IDH1 mAb (RMab-3；mouse IgG1, kappa)	specific for IDH1	IHC, WB	RMab-3		BD MBL
anti-IDH1 mAb (RcMab-1；rat IgG2a, kappa)	specific for IDH1	IHC, WB	RcMab-1		abcam CST MBL
anti-IDH2 mAb (RMab-22；mouse IgG2b, kappa)	specific for IDH2	IHC, WB	RMab-22		MBL
anti-IDH2 mAb (KrMab-3；mouse IgG2b, kappa)	specific for IDH2	IHC, WB	KrMab-3		CST BioLegend MBL
anti-mIDH1/2 mAb (MsMab-1；mouse IgG1, kappa)	specific for mutated IDH1/2	IHC, WB （IHCのref）	TJEM Brain Tumor Pathol Cancer Med	○	abcam Merck
anti-mIDH1/2 mAb (MsMab-2；rat IgG2a, kappa)	specific for mutated IDH1/2	IHC, WB	MsMab-2	○	MBL

　Back to list

TERT	Character	Application	Ref	Gene cloning	Company
anti-hTERT mAb （TpMab-1；mouse IgG1, kappa）	specific for phosphorylated threonine 249 of hTERT	IHC, WB, ELISA	TpMab-1 （press release）	○
anti-hTERT mAb （TpMab-2；mouse IgG1, kappa）	specific for phosphorylated threonine 249 of hTERT	IHC, WB, ELISA		○
anti-hTERT mAb （TpMab-3；mouse IgG1, kappa）	specific for phosphorylated threonine 249 of hTERT	IHC, WB, ELISA	TpMab-3 （press release）	○	in preparation
anti-hTERT mAb （TwMab-1；mouse IgG1, kappa）	specific for hTERT	IHC, WB, ELISA	TwMab-1	○	in preparation
anti-hTERT mAb （TMab-6；mouse IgM, kappa）	specific for hTERT	IHC	TMab-6 TMab-6_epitope	○

　Back to list



＜Monoclonal antibodies for SARS-CoV-2＞

SARS-CoV-2 (S1 RBD)	Character	Application	Ref	Gene cloning	Company
anti-SARS-CoV-2 S1-RBD mAb （CvMab-1；mouse IgG1, kappa）	specific for SARS-CoV-2 S1-RBD epitope: 319-338aa。 RBD：Receptor binding domain	ELISA,WB, IHC		○
anti- SARS-CoV-2 S1-RBD mAb （CvMab-2；mouse IgG1, kappa）	specific for SARS-CoV-2 S1-RBD epitope: 459-478aa	ELISA, WB, IHC, neutralization
anti-SARS-CoV-2 S1-RBD mAb （CvMab-3；mouse IgG1, kappa）	specific for SARS-CoV-2 S1-RBD epitope: 469-478aa。	ELISA,WB, IHC, neutralization
anti SARS-CoV-2 S1-RBD mAb （CvMab-6；mouse IgG1, kappa）	specific for SARS-CoV-2 S1-RBD epitope: 459-478aa。	ELISA, WB, IHC, neutralization	CvMab-6	○
anti-SARS-CoV-2 S1-RBD mAb （CvMab-7；mouse IgM, kappa）	specific for SARS-CoV-2 S1-RBD epitope:459-478aa。	ELISA, WB, IHC, neutralization		○
anti-SARS-CoV-2 S1-RBD mAb （CvMab-13；mouse IgG1, kappa）	specific for SARS-CoV-2 S1-RBD epitope: 459-478aa。	ELISA, WB, IHC		○
anti-SARS-CoV-2 S1-RBD mAb （CvMab-17；mouse IgG1, kappa）	specific for SARS-CoV-2 S1-RBD epitope: 459-478aa。	ELISA, WB, neutralization, IHC
anti-SARS-CoV-2 S1-RBD mAb （CvMab-18；mouse IgG1, kappa）	specific for SARS-CoV-2 S1-RBD epitope: 459-478aa。	ELISA, WB, neutralization, IHC
anti-SARS-CoV-2 S1-RBD mAb （CvMab-24；mouse IgG1, kappa）	specific for SARS-CoV-2 S1-RBD epitope: 459-478aa。	ELISA, WB, IHC, neutralization
anti-SARS-CoV-2 S1-RBD mAb （CvMab-25；mouse IgG1, kappa）	specific for SARS-CoV-2 S1-RBD epitope: 459-478aa。	ELISA, IHC, WB

Back to list

SARS-CoV-2 (S1 N terminus)	Character	Application	Ref	Gene cloning	Company
anti-SARS-CoV-2 mAb （CvMab-32；mouse IgG2b, kappa）	specific for SARS-CoV-2 S1N terminus	ELISA, IHC, WB

Back to list

SARS-CoV-2 (S2)	Character	Application	Ref	Gene cloning	Company
anti-SARS-CoV-2 mAb （CvMab-36；mouse IgG1, kappa）	specific for SARS-CoV-2 S2	ELISA, WB
anti-SARS-CoV-2 mAb （CvMab-62；mouse　IgG1, kappa）	specific for SARS-CoV-2 S2	ELISA		○
anti-SARS-CoV-2 mAb （humCvMab-62；human　IgG1, kappa）	specific for SARS-CoV-2 S2	ELISA		○

Back to list

SARS-CoV-2 (bi-specific)	Character	Application	Ref	Gene cloning	Company
anti-SARS-CoV-2 mAb （CvMab-bis1）	specific for SARS-CoV-2 S1+S2 bispecific mAb CvMab-6-H_CvM62scFv			○
anti-SARS-CoV-2 mAb （CvMab-bis2）	specific for SARS-CoV-2 S1+S2 bispecific mAb CvMab-6-L_CvM62scFv			○
anti-SARS-CoV-2 mAb （CvMab-bis3）	specific for SARS-CoV-2 S1+S2 bispecific mAb CvMab-62-H_CvM6scFv			○
anti-SARS-CoV-2 mAb （CvMab-bis4）	specific for SARS-CoV-2 S1+S2 bispecific mAb CvMab-62-L_CvM6scFv			○
CvMab-62-H_Bebtelovimab-scFv (bispecific)	specific for SARS-CoV-2 S1+S2			○
humCvMab-62-H_Bebtelovimab-scFv (bispecific)	specific for SARS-CoV-2 S1+S2			○
CvMab-62-H_Cilgavimab-scFv (bispecific)	specific for SARS-CoV-2 S1+S2			○

Back to list

SARS-CoV-2 (humanized)	Character	Application	Ref	Gene cloning	Company
Bebtelovimab (human IgG1, lambda)	specific for SARS-CoV-2 S1 (sequence) (Lancet)	Neutralization; weak activity for all variants		○
Cilgavimab (human IgG1, kappa)	specific for SARS-CoV-2 S1 (sequence) (Lancet) Cilgavimab plus tixagevimab (EVUSHELD)	Neutralization; weak activity for BA.2; resistant for BA.4/5		○
Casirivimab (human IgG1, kappa)	specific for SARS-CoV-2 S1 (sequence) (Lancet) Casirivimab plus imdevimab (Ronapreve)	Neutralization; weak activity for Omicron		○
Bamlanivimab (human IgG1, kappa)	specific for SARS-CoV-2 S1 (sequence) (Lancet)	Neutralization; no activity for Omicron		○
Bebtelovimab-scFv (scFv-Fc of human IgG1)	specific for SARS-CoV-2 S1			○
Cilgavimab-scFv (scFv-Fc of human IgG1)	specific for SARS-CoV-2 S1			○

Back to list

RdRP	Character	Application	Ref	Gene cloning	Company
anti-RdRP mAb （RdMab-2；mouse IgG2a, kappa）	specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP; Immunogen: TRALTAESHVDTDLTKPYIC; distinguishes nsp12 of SARS-CoV-2 from that of SARS-CoV	ELISA, WB, IP, ICC	RdMab-2	○	in preparation
anti-RdRP mAb （RdMab-13；mouse IgM, kappa）	specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP; Immunogen: TRALTAESHVDTDLTKPYIC; distinguishes nsp12 of SARS-CoV-2 from that of SARS-CoV	ELISA, WB	RdMab-13
anti-RdRP mAb （RdMab-15；mouse IgG1, kappa）	specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP ; Immunogen: RHTFSNYQHEETIYNLLKDC	ELISA, WB	RdMab-15
anti-RdRP mAb （RdMab-16；mouse IgG1, kappa）	specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP ; Immunogen: RHTFSNYQHEETIYNLLKDC	ELISA, WB	RdMab-16
anti-RdRP mAb （RdMab-20；mouse IgG2b, kappa）	specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP; Immunogen: TRALTAESHVDTDLTKPYIC; distinguishes nsp12 of SARS-CoV-2 from that of SARS-CoV	ELISA, WB	RdMab-20

Back to list



＜anti-dog protein monoclonal antibodies＞

dog PDPN	Character	Application	Ref	Gene cloning	Company
anti-dog PDPN mAb （PMab-38；mouse IgG1, kappa）	specific for dog PDPN	IHC, WB, FACS	PMab-38; SCC melanoma epitope	○	zenogen Wako
anti-dog PDPN mAb （P38Bf；dog IgGB, kappa）	core fucose-deficient type B of PMab-38	IHC, WB, FACS	P38Bf P38B_in vivo ADC	○
anti-dog PDPN mAb （PMab-48；mouse IgG1, kappa）	specific for dog PDPN	IHC, WB, FACS	PMab-48 epitope	○	zenogen
dog EGFR	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb （134-mG2a-f；mouse IgG2a, kappa）	core fucose-deficient mouse IgG2a version of EMab-134; reacts with domain-III	FACS, WB, IHC, ADCC, CDC, antitumor activities	CHO/dEGFR Osteosarcoma Fibroblastic Mammary	○
anti-EGFR mAb （E134Bf；canine IgGB, kappa）	core fucose-deficient canine IgGB version of EMab-134; specific for EGFR	FACS, WB, IHC, ADCC, CDC, antitumor activities	Mammary Fibro & Osteo	○
dog HER2	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb （H77Bf；canine IgGB, kappa）	core fucose-deficient canine IgGB version of H2Mab-77	FACS, WB, IHC, ADCC/CDC, antitumor activities	H77Bf OS fibro	○
anti-HER2 mAb （H2Mab-41；mouse IgG2b, kappa）	specific for HER2; crossreacts with dog HER2; domain-IV	FACS, antitumor activities	H2Mab-41 dogHER2	○
EGFR-HER2 (bispecific)	Character	Application	Ref	Gene cloning	Company
anti-dog EGFR-dog HER2 mAb （E134B-H77scFv-f）	bispecific mAb for EGFR and HER2	FACS, WB, IHC, ADCC, CDC, antitumor activities	E134B-H77scFv-f	○
dog PD-L1	Character	Application	Ref	Gene cloning	Company
anti-dog PD-L1 mAb （L1Mab-347；mouse IgG1, kappa）	specific for dog PD-L1	FACS, IHC		○
anti-dog PD-L1 mAb （L1Mab-348； mouse IgG1, kappa）	specific for dog PD-L1 (intracellular domain)	ELISA
anti-dog PD-L1 mAb （L1Mab-349； mouse IgG1, kappa）	specific for dog PD-L1 (intracellular domain)	ELISA
anti-dog PD-L1 mAb （L1Mab-350； mouse IgG1, kappa）	specific for dog PD-L1 (intracellular domain)	ELISA
anti-dog PD-L1 mAb （L1Mab-351； mouse IgG1, kappa）	specific for dog PD-L1 (intracellular domain)	ELISA
anti-dog PD-L1 mAb （L1Mab-352； mouse IgG1, kappa）	specific for dog PD-L1 (intracellular domain)	ELISA, IHC	L1Mab-352	○
anti-dog PD-L1 mAb （L1Mab-353； mouse IgG1, kappa）	specific for dog PD-L1 (intracellular domain)	ELISA
anti-dog PD-L1 mAb （L1Mab-354； mouse IgG1, kappa）	specific for dog PD-L1 (intracellular domain)	ELISA, IHC	L1Mab-354	○
anti-dog PD-L1 mAb （L1Mab-355； mouse IgG1, kappa）	specific for dog PD-L1 (intracellular domain)	ELISA
anti-dog PD-L1 mAb （L1Mab-356； mouse IgG1, kappa）	specific for dog PD-L1 (intracellular domain)	ELISA

　Back to list



CasMab関連

PDPN	Character	Application	Ref	Gene cloning	Company
anti-hPDPN mAb (LpMab-2；mouse IgG1, kappa)	CasMab	IHC, WB, FACS	Cells2022 LpMab-2 patent	○	zenogen
anti-human PDPN mAb（chLpMab-2; human IgG1）	CasMab for human PDPN; mouse-human chimeric mAb originated from LpMab-2	IP、IHC, WB, FACS	chLpMab-2	○	zenogen
anti-hPDPN mAb (LpMab-23；mouse IgG1, kappa)	CasMab	IHC, WB, FACS	LpMab-23 IHC patent	○	BD exbio zenogen
anti-human PDPN mAb（chLpMab-23；human IgG1）	CasMab for human PDPN; mouse-human chimeric mAb originated from LpMab-23	IHC, WB, FACS	chLpMab-23	○	zenogen
anti-human PDPN mAb（humLpMab-23；human IgG1）	CasMab for human PDPN; humanized mAb originated from LpMab-23	IHC, WB, FACS	humLpMab-23	○	zenogen
anti-hPDPN mAb (PMab-117；rat IgM, kappa)	CasMab	FACS	Cells2022 patent	○	zenogen

Back to list

Podocalyxin	Character	Application	Ref	Gene cloning	Company
anti-PODXL mAb （PcMab-6；mouse IgG1, kappa）	anti-PODXL CasMab	FACS	patent	○	zenogen
anti-PODXL mAb （PcMab-6-mG2a-f；mouse IgG2a）	anti-PODXL CasMab; IgG2a version of PcMab-6	FACS, ADCC・CDC		○	zenogen
anti-PODXL mAb （humPcMab-6；human IgG1）	CasMab for PODXL; humanized mAb originated from PcMab-6	FACS		○	zenogen
anti-PODXL mAb （PcMab-60；mouse IgM, kappa）	anti-PODXL CasMab	FACS	PcMab-60 epitope patent	○	zenogen
anti-PODXL mAb （60-mG2a；mouse IgG2a, kappa）	anti-PODXL CasMab; IgG2a version of PcMab-60	FACS, ADCC/CDC	60-mG2a	○	zenogen
anti-PODXL mAb （60-mG2a-f；mouse IgG2a, kappa）	anti-PODXL CasMab, core fucose-deficient IgG2a version of PcMab-60	FACS, ADCC/CDC, antitumor activities	60-mG2a-f	○	zenogen

Back to list

CD44s	Character	Application	Ref	Gene cloning	Company
anti-CD44s mAb （C44Mab-1012； mouse IgM, kappa）	Mab1 for CD44s (exon-6)	FACS		○
anti-CD44s mAb （C44Mab-1075； mouse IgG2a, kappa）	Mab2 for CD44s (exon-6)	FACS		○
anti-CD44s mAb （C44Mab-1095； mouse IgG1, kappa）	Mab3 for CD44s (exon-6)	FACS		○

Back to list

CD44v3	Character	Application	Ref	Gene cloning	Company
anti-CD44v3 mAb （C44Mab-1080； mouse IgG1, kappa）	Mab6 for CD44v3	FACS		○
anti-CD44v3 mAb （C44Mab-1006； mouse IgG1, kappa）	Mab11 for CD44v3	FACS		○
CD44v5	Character	Application	Ref	Gene cloning	Company
anti-CD44v5 mAb （C44Mab-1088； mouse IgG1, kappa）	Mab8 for CD44v5	FACS		○
anti-CD44v5 mAb （C44Mab-1003； mouse IgG1, kappa）	Mab12 for CD44v5	FACS		○
CD44v6	Character	Application	Ref	Gene cloning	Company
anti-CD44v6 mAb （C44Mab-1081； mouse IgG1, kappa）	Mab7 for CD44v6	FACS		○
anti-CD44v6 mAb （C44Mab-1089； mouse IgM, kappa）	Mab9 for CD44v6（検証中）	FACS		○
anti-CD44v6 mAb （C44Mab-1009； mouse IgG1, kappa）	Mab13 for CD44v6	FACS		○
anti-CD44v6 mAb （C44Mab-1074； mouse IgM, kappa）	Mab14 for CD44v6	FACS		○
anti-CD44v6 mAb （C44Mab-1079； mouse IgG1, kappa）	Mab15 for CD44v6	FACS		○
anti-CD44v6 mAb （C44Mab-1092； mouse IgG3, kappa）	Mab16 for CD44v6	FACS		○
CD44v7	Character	Application	Ref	Gene cloning	Company
anti-CD44v7 mAb （C44Mab-1030； mouse IgM, kappa）	Mab4 for CD44v7	FACS		○
anti-CD44v7 mAb （C44Mab-1048； mouse IgG1, kappa）	Mab5 for CD44v7	FACS		○
anti-CD44v7 mAb （C44Mab-1034； mouse IgG1, kappa）	Mab10 for CD44v7	FACS		○

Back to list

EpCAM	Character	Application	Ref	Gene cloning	Company
anti-EpCAM mAb （EpMab-1123;mouse IgM, kappa）	Mab1 for EpCAM	FACS		×
anti-EpCAM mAb （EpMab-1138;mouse IgM, kappa）	Mab2 for EpCAM	FACS		×
anti-EpCAM mAb （EpMab-1147;mouse IgG1, kappa）	Mab3 for EpCAM	FACS		○
anti-EpCAM mAb （EpMab-1007;mouse IgG1, kappa）	Mab4 for EpCAM	FACS		○
anti-EpCAM mAb （EpMab-1013;mouse IgG1, kappa）	Mab5 for EpCAM	FACS		○
anti-EpCAM mAb （EpMab-1022;mouse IgG1, kappa）	Mab6 for EpCAM	FACS		○
anti-EpCAM mAb （EpMab-1069;mouse IgG1, kappa）	Mab7 for EpCAM	FACS		○

Back to list

TROP2	Character	Application	Ref	Gene cloning	Company
anti-TROP2 mAb （TrMab-1100; mouse IgG1, kappa）	Mab1 for human TROP2	FACS		○
anti-TROP2 mAb （TrMab-1148; mouse IgG1, kappa）	Mab3 for human TROP2	FACS		○
anti-TROP2 mAb （TrMab-1156; mouse IgG2b, kappa）	Mab4 for human TROP2	FACS		○

Back to list

EGFR	Character	Application	Ref	Gene cloning	Company
anti EGFR mAb （EMab-1048；mouse IgM,kappa）	Mab1 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1059；mouse IgG1,kappa）	Mab2 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1073；mouse IgG1,kappa）	Mab3 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1092；mouse IgG1,kappa）	Mab4 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1094；mouse IgG1,kappa）	Mab5 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1096；mouse IgM,kappa）	Mab6 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1102；mouse IgG1,kappa）	Mab7 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1106；mouse IgG1,kappa）	Mab8 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1107；mouse IgG1,kappa）	Mab9 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1111；mouse IgG1,kappa）	Mab10 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1119；mouse IgG1,kappa）	Mab11 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1122；mouse IgG1,kappa）	Mab12 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1141；mouse IgG1,kappa）	Mab13 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1146；mouse IgG1,kappa）	Mab14 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1152；mouse IgG1,kappa）	Mab15 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1153；mouse IgG1,kappa）	Mab16 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1190；mouse IgG1,kappa）	Mab17 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1196；mouse IgG1,kappa）	Mab18 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1225；mouse IgG1,kappa）	Mab19 for EGFR	FACS		◯	ONO
anti EGFR mAb （EMab-1243；mouse IgM,kappa）	Mab20 for EGFR	FACS		◯	ONO

Back to list

HER2 （CD340)	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb (H2Mab-214; mouse IgG1,kappa)	Mab-1; specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC	H2Mab-214 PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-214-mG2af; mouse IgG2a,kappa)	Mab-1; specific for HER2; domain-IV	FACS, WB, IHC	H2Mab-214-mG2a-f	○	ONO
anti-HER2 mAb (H2Mab-214-hG1; human IgG1,kappa)	Mab-1; specific for HER2; domain-IV	FACS, WB, IHC		○	ONO
anti-HER2 mAb (H2Mab-250; mouse IgG1,kappa)	Mab-2; specific for HER2; domain-IV	FACS, WB, IHC	H2Mab-250 PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-250-mG2af; mouse IgG2a,kappa)	Mab-2; specific for HER2; domain-IV	FACS, WB, IHC		○	ONO
anti-HER2 mAb (H2Mab-250-hG1; human IgG1,kappa)	Mab-2; specific for HER2; domain-IV	FACS, WB, IHC		○	ONO
anti-HER2 mAb (H2Mab-1279; mouse IgG3,kappa)	Mab-3; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1280; mouse IgG1,kappa)	Mab-4; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1281; mouse IgG1,kappa)	Mab-5; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1282; mouse IgG2a,kappa)	Mab-6; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1283; mouse IgG1,kappa)	Mab-7; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1284; mouse IgG1,kappa)	Mab-8; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1285; mouse IgG3,kappa)	Mab-9; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1286; mouse IgG1,kappa)	Mab-10; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1287; mouse IgG1,kappa)	Mab-11; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1288; mouse IgG1,kappa)	Mab-12; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1289; mouse IgG1,kappa)	Mab-13; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1290; mouse IgG1,kappa)	Mab-14; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1291; mouse IgG3,kappa)	Mab-15; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1292; mouse IgG3,kappa)	Mab-16; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1293; mouse IgG3,kappa)	Mab-17; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1294; mouse IgG1,kappa)	Mab-18; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1295; mouse IgG1,kappa)	Mab-19; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1296; mouse IgG1,kappa)	Mab-20; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1297; mouse IgG2a,kappa)	Mab-21; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1298; mouse IgG1,kappa)	Mab-22; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb (H2Mab-1299; mouse IgG1,kappa)	Mab-23; specific for HER2; domain-IV	FACS, WB, IHC	PCT/JP2021/043538	○	ONO
anti-HER2 mAb （H2Mab-1301; rat IgG2a, lambda）	Mab30; specific for mouse HER2; cross-react with HER2 (human; domiain-I); does not cross-react with dog HER2	FACS		◯
anti-HER2 mAb （H2Mab-1301-hG1 ;human IgG1,kappa）	specific for mouse HER2; cross-react with HER2 (human) does not cross-react with dog HER2	FACS		ongoing
anti-HER2 mAb （H2Mab-1316; rat IgG2a, kappa）	Mab-31; specific for mouse HER2; cross-react with HER2 (human; domiain-I); does not cross-react with dog HER2	FACS		◯
anti-HER2 mAb （H2Mab-1316-hG1 ;human IgG1,kappa）	specific for mouse HER2; cross-react with HER2 (human) does not cross-react with dog HER2	FACS		ongoing
anti-HER2 mAb （H2Mab-1319; rat IgG2a, kappa）	Mab-32; specific for mouse HER2; cross-react with HER2 (human; domiain-I); does not cross-react with dog HER2	FACS		◯
anti-HER2 mAb （H2Mab-1319-hG1 ;human IgG1,kappa）	specific for mouse HER2; cross-react with HER2 (human) does not cross-react with dog HER2	FACS		ongoing
anti-HER2 mAb （H2Mab-1180; mouse IgG1, kappa）	Mab-33; specific for human HER2 does not cross-react with endogenous dog HER2	FACS		ongoing
anti-HER2 mAb （H2Mab-1245; mouse IgG1,kappa）	Mab-34; specific for human HER2 does not cross-react with endogenous dog HER2	FACS		○
anti-HER2 mAb （H2Mab-1268; mouse IgG1,kappa）	Mab-35; specific for HER2 or endogenous dog HER2	FACS		ongoing
anti-HER2 mAb （H2Mab-1190; mouse IgG1,kappa）	Mab-36; specific for HER2 does not cross-react with endogenous dog HER2	FACS		ongoing
anti-HER2 mAb （H2Mab-1262; mouse IgG1,kappa）	Mab-37; specific for HER2 does not cross-react with endogenous dog HER2	FACS		ongoing
anti-HER2 mAb （H2Mab-1278; mouse IgG1,kappa）	Mab-38; specific for HER2 or endogenous dog HER2	FACS		ongoing

Back to list

HER3	Character	Application	Ref	Gene cloning	Company
anti HER3 mAb （H3Mab-1059; mouse IgG1,kappa）	Mab1 for HER3	FACS		○
anti HER3 mAb （H3Mab-1170; mouse IgG1,kappa）	Mab2 for HER3	FACS		○

Back to list